Alternative Acts: Oncogenic Splicing of Steroidogenic Enzymes in Prostate Cancer

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-3410
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Modulation of Oncogenic Transcription and Alternative Splicing by -Catenin and an RNA Aptamer in Colon Cancer Cells

Cancer Research
Cancer ResearchOncology
2006English

Upregulation of Scavenger Receptor B1 Is Required for Steroidogenic and Non-Steroidogenic Cholesterol Metabolism in Prostate Cancer

Cancer Research
Cancer ResearchOncology
2019English

TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer

Cancer Cell
Cancer ResearchOncologyCell Biology
2016English

Roles of Alternative Splicing in the Pathogenesis of Lung Cancer

Cancer Cell & Microenvironment
2017English

Identification of Alternative Splicing Markers for Breast Cancer

Cancer Research
Cancer ResearchOncology
2008English

Chemoresistance‑associated Alternative Splicing Signatures in Serous Ovarian Cancer

Oncology Letters
Cancer ResearchOncology
2020English

Revealing the Determinants of Widespread Alternative Splicing Perturbation in Cancer

Cell Reports
BiochemistryGeneticsMolecular Biology
2017English

MBNL1 Alternative Splicing Isoforms Play Opposing Roles in Cancer

Life Science Alliance
Plant ScienceEcologyGeneticsMolecular BiologyBiochemistryMutagenesisHealthToxicology
2018English

PRMT5 Regulates DNA Repair by Controlling the Alternative Splicing of Histone-Modifying Enzymes

Cell Reports
BiochemistryGeneticsMolecular Biology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy